Our pipeline

With a strong portfolio in Dermatology, we have been working to expand in areas of Cardiology, Neurosurgery and Hepatology. We are keen to venture into Oncology as Cancer is the most deadliest disease worldwide. We will strive to achieve this with our R&D partners based in the UK.